| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 03/21/2007 | CN1931827A 2- and 2,5-substituted phenylketo-enols |
| 03/21/2007 | CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 03/21/2007 | CN1305852C Diaryl ethers as opioid receptor antagonist |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/20/2007 | US7192979 EP4 receptor selective agonist in the treatment of osteoporosis |
| 03/20/2007 | US7192978 Pyrrolidinium derivatives |
| 03/20/2007 | US7192976 3-substituted pyrazoles; cell proliferation and angiogenesis promoters; antiapoptotosis and antifibrosis activity |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192971 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/20/2007 | US7192968 Ethylenediamine derivatives |
| 03/20/2007 | US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192957 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/20/2007 | US7192535 Conjugated molecule and electroluminescent device thereof and electronic device having the electroluminescent device |
| 03/20/2007 | CA2211320C 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2 |
| 03/15/2007 | WO2007030574A2 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| 03/15/2007 | WO2007030559A2 1, 3-disubstituted indole derivatives for use as ppar modulators |
| 03/15/2007 | WO2007030366A1 Regioselective process for preparing benzimidazole thiophenes |
| 03/15/2007 | WO2007030361A2 Benzimidazole thiophene compounds as plk inhibitors |
| 03/15/2007 | WO2007030359A1 Benzimidazole thiophene compounds as plk modulators |
| 03/15/2007 | WO2007029587A1 β SECRETASE INHIBITOR |
| 03/15/2007 | WO2007029037A2 Class iia histone deacetylase (hdac) substrate |
| 03/15/2007 | WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | WO2007029035A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | WO2007028445A1 6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives |
| 03/15/2007 | US20070060631 2-cyanomethyl-5-(3-substituted phenyl or 5-substituted thien-2-yl)-2H-tetrazoles; agricultural fungicides such as for rice blast |
| 03/15/2007 | US20070060629 Large conductance calcium-activated k channel opener |
| 03/15/2007 | US20070060623 Acid secretion inhibitor |
| 03/15/2007 | US20070060619 Nicotinamide-based kinase inhibitors |
| 03/15/2007 | US20070060616 Methods for treating, preventing and managing chronic lymphocytic leukemia with indazole compounds |
| 03/15/2007 | US20070060596 Selective modulators of prostaglandin E2 at EP1 receptors; analgesics, antiinflammatory agents; neurodegenerative diseases, bone or renal disorders; 1-({5-bromo-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazole-3-carboxylic acid |
| 03/15/2007 | US20070060593 4-Carboxamido quinoline derivatives for use as nk-2 and nk-3 |
| 03/15/2007 | US20070060582 1,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 03/15/2007 | US20070060576 Process for preparing benzimidazole thiophenes |
| 03/15/2007 | US20070060570 Sulfopyrroles |
| 03/15/2007 | US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors |
| 03/15/2007 | US20070060568 5HT2c receptor modulators |
| 03/15/2007 | US20070060566 Benzazepine derivatives as histamine h3 antagonists |
| 03/15/2007 | US20070057229 Compound having phenylacetylene structure, liquid crystal composition, polymer, optically anisotropic product, optical or liquid crystal element, dibenzothiophene compound, intermediate, and process for producing the same |
| 03/15/2007 | CA2621879A1 Benzimidazole thiophene compounds as plk inhibitors |
| 03/15/2007 | CA2621474A1 1,3-disubstituted indole derivatives for use as ppar modulators |
| 03/15/2007 | CA2621448A1 Class iia histone deacetylase (hdac) substrate |
| 03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | CA2621443A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | CA2621275A1 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| 03/15/2007 | CA2621073A1 Regioselective process for preparing benzimidazole thiophenes |
| 03/14/2007 | EP1762567A1 Pyrazole derivatives for treating HIV |
| 03/14/2007 | EP1761614A1 Electroluminescent materials and devices |
| 03/14/2007 | EP1761531A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 03/14/2007 | EP1761524A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists |
| 03/14/2007 | EP1761522A1 Compounds and methods for treating dyslipidemia |
| 03/14/2007 | EP1761518A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 03/14/2007 | EP1761506A1 Substituted quinazolones as anti-cancer agents |
| 03/14/2007 | EP1761505A1 Pyrimidine urea derivatives as kinase inhibitors |
| 03/14/2007 | EP1761497A2 Azadecalin glucocorticoid receptor modulators |
| 03/14/2007 | EP1761494A1 Chemical compounds i |
| 03/14/2007 | EP1517895B1 8-(biaryl) quinoline pde4 inhibitors |
| 03/14/2007 | EP1040103B1 Anilide derivative, production and use thereof |
| 03/14/2007 | CN1930157A Silylierte carboxamide |
| 03/14/2007 | CN1930135A Diaminopyrimidines as P2X3 and P2X2/3 antagonists |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1929848A Benzodiazepines for treating or preventing or preventing RSV infection |
| 03/14/2007 | CN1929738A Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides |
| 03/14/2007 | CN1304390C Novel gamma secretase inhibitors |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304375C Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions |
| 03/14/2007 | CN1304374C Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition |
| 03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy |
| 03/13/2007 | US7189741 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/13/2007 | US7189738 Substituted isoindoles and their use thereof |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189725 Administering (-)3-((S)-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)(3-thienyl)methyl)phenol or a pharmaceutically acceptable salt thereof for reducing ischemic damage |
| 03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
| 03/13/2007 | US7189718 viricides; polymerase inhibitor; therapy for genetic engineered viruses |
| 03/13/2007 | CA2274592C Pyrazole derivatives |
| 03/08/2007 | WO2007028131A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 03/08/2007 | WO2007028083A2 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | WO2007028082A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | WO2007027842A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 03/08/2007 | WO2007026959A2 Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders |
| 03/08/2007 | WO2007026916A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 03/08/2007 | WO2007026664A1 Sulfonamide compound |
| 03/08/2007 | WO2007026375A1 Process for the preparation of losartan |
| 03/08/2007 | WO2007026157A1 Atm inhibitor |
| 03/08/2007 | WO2007025949A1 Novel cycloalkane carboxamides as factor xa inhibitors |
| 03/08/2007 | WO2007025940A1 Substituted biaryls and their use as factor xa inhibitors |
| 03/08/2007 | WO2007025534A1 Fredericamycin derivatives |
| 03/08/2007 | WO2007005668A3 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 03/08/2007 | WO2006067392A3 Indole derivatives for the treatment of tuberculosis |
| 03/08/2007 | US20070054923 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054922 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054920 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054910 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 03/08/2007 | US20070054907 Peroxisome Proliferator-Activated Receptor (PPAR) receptor modulators such as Ethyl(4-{4-[5-(4-tert-butylphenyl)-4-methyl-4H-[1,2,4]-triazol-3-ylsulfanyl]-2-heptyloxybenzylamino}phenyl)acetate, used in dermatology, cardiovascular diseases, immunology and/or diseases linked to lipid metabolism |
| 03/08/2007 | US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy |